Combined drug for treating colorectal cancer
A technology for combined drug use and colorectal cancer, which can be applied to medical preparations containing active ingredients, antitumor drugs, drug combinations, etc., and can solve the problem of high mortality of colorectal cancer
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0014] A combination drug for treating colorectal cancer, which is composed of diosgenin, baicalin A, fucoidan and psoralen; the mass ratio of diosgenin, baicalin A, fucoidan and psoralen is 4 :1:0.5:2.
Embodiment 2
[0016] A combination drug for treating colorectal cancer, which is composed of diosgenin, baicalin A, fucoidan and psoralen; the mass ratio of diosgenin, baicalin A, fucoidan and psoralen is 4 :2:1:3.
Embodiment 3
[0018] A combination drug for treating colorectal cancer, which is composed of diosgenin, baicalin A, fucoidan and psoralen; the mass ratio of diosgenin, baicalin A, fucoidan and psoralen is 4 :1.5:0.75:2.5.
PUM

Abstract
Description
Claims
Application Information

- Generate Ideas
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com